|
HS Code |
446757 |
| Product Name | 2,4-Dimethoxybenzylamine Hydrochloride |
| Cas Number | 2273-21-4 |
| Molecular Formula | C9H14ClNO2 |
| Molecular Weight | 203.67 g/mol |
| Appearance | White to off-white crystalline powder |
| Purity | Typically ≥98% |
| Melting Point | 182-186°C |
| Solubility | Soluble in water and methanol |
| Storage Temperature | 2-8°C |
| Synonyms | 2,4-DMBA Hydrochloride; 2,4-Dimethoxybenzylamine HCl |
| Mdl Number | MFCD00084228 |
| Inchikey | BPFOWYCJJPXZAM-UHFFFAOYSA-N |
As an accredited 2,4-Dimethoxybenzylamine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging contains 25 grams of 2,4-Dimethoxybenzylamine Hydrochloride, sealed in an amber glass bottle with a secure screw cap. |
| Shipping | 2,4-Dimethoxybenzylamine Hydrochloride is shipped in tightly sealed containers to protect it from moisture and contamination. The packaging complies with chemical safety regulations, and the substance is labeled appropriately. Shipment is typically via ground or air, following hazardous material guidelines, with proper documentation and handling instructions to ensure safe delivery. |
| Storage | 2,4-Dimethoxybenzylamine Hydrochloride should be stored in a tightly sealed container, protected from light and moisture. Keep at room temperature or as specified by the manufacturer, ideally between 2–8°C. Store in a well-ventilated area, away from incompatible substances such as strong oxidizers, acids, or bases. Ensure proper labeling and prevent prolonged exposure to air and humidity. |
Applications of 2,4-Dimethoxybenzylamine Hydrochloride in Industrial ManufacturingWe provide 2,4-Dimethoxybenzylamine Hydrochloride to support advanced chemical synthesis and downstream innovation across select industries. Our understanding of industrial best practices ensures our material consistently meets customer process and regulatory requirements. Below, explore real-world application scenarios anchored in compliance, optimized dosing, integration steps, and end-product specifics. 1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredient (API) SynthesisMajor pharmaceutical manufacturers use this compound as a key protected amine or side-chain builder in multi-step syntheses of certain APIs, particularly those derived from benzylamine-based scaffolds. It facilitates selective amination and functional group modifications, often acting as a precursor or protecting group in route design for target molecules including antihypertensives or neuroactive drugs. Our production grade aligns with regulatory controls for material upstream of GMP manufacturing lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Building Block for Agrochemical SynthesisChemical synthesis plants employ this compound as an intermediate for the preparation of crop protection agents, incorporating it as a nucleophile or amine donor in constructing herbicide or pesticide active molecule backbones. It serves a dual function as a protected precursor or as a direct chain extender, fitting production routes targeting amine-functionalized aromatic agro-agents. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Material Synthesis: Specialty Colorants and DyesProducers of performance dyes incorporate this compound for its unique electron-donating methoxy groups in the synthesis of specialty colorants, especially those requiring custom amine substitutions to enhance chromatic discrimination or solvent compatibility. Industrial dye-making leverages it as a key coupling agent or protected amine for later functionalization steps. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Organic Synthesis Reagent for Research and Development ScalabilityR&D departments in pharmaceutical and fine chemical companies select this intermediate for custom synthesis due to its predictable protection and deprotection profiles, allowing for targeted exploration of new aromatic amine molecules. It supports both library generation and pilot plant scale-ups, with material supplied according to high-purity specifications suitable for preclinical or advanced process development stages. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2,4-Dimethoxybenzylamine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
We have spent over a decade producing 2,4-Dimethoxybenzylamine Hydrochloride—model DMBA-HCl—right here in our manufacturing facility. Over the years, our work with this compound has revealed both its versatility and the precise technical demands it places on producers. This direct experience shapes every batch that leaves our plant. DMBA-HCl always draws requests from pharmaceutical research groups, custom synthesis labs, and advanced material scientists due to its reliable performance and adaptability to both scale-up and process development.
Many see DMBA-HCl as a simple intermediate. That’s what the textbooks say: an aromatic amine, useful for protection chemistry, for coupling steps, as a building block in multi-step syntheses. But these labels do not capture how much labor stands behind every kilogram—hours making sure the crystalline product stays bright, the hydrochloride remains stable, and impurity levels drop below thresholds that matter in real downstream chemistry. Early in our experience, even small changes in moisture led to trouble. Genuine experience cannot be replaced by certificate printouts or mere distribution. Our confidence in the product only comes from this hands-on preparation and repeated analysis.
Chemists use DMBA-HCl for its purity and chemical consistency. Typical requests focus on purity above 98%, but after hundreds of batches, we learned the headaches that come from pushing higher. Water content sits near the detection limit, and chloride balance is always freshly confirmed—not as an afterthought, but as a key check before shipment. We have implemented in-process controls that do not just measure the outcome but actively guide the chemistry, helping us anticipate and solve potential pitfalls before the final assay.
Customers expect a bright-white to off-white crystalline powder. Granule size seems minor until small-scale syntheses stall due to poor solubility or filtration challenges. Based on frequent customer feedback, our granulation methods evolved. We now produce a tighter particle size distribution, which saves customers from extended dissolution steps and lets lab procedures flow without interruption. This improves not only convenience but repeatability for those developing new routes.
Nearly every inquiry starts with the same question: “Can your DMBA-HCl meet our consistency requirements for scale-up or downstream coupling?” The answer comes not from hope, but from the routine quality profiles we generate during each synthesis campaign. DMBA-HCl often plays an early role in protecting and deprotecting sensitive amines, acting as a masked intermediate in more complex molecules. Pharmas come to us not because DMBA-HCl is rare, but because inconsistency threatens main reactions.
Our production supports both small-batch orders for process development and multi-kilogram lots for commercial production. Researchers pursuing heterocyclic cores, peptide side-chains, or novel ligands frequently depend on DMBA-HCl’s stable hydrochloride salt form. Among its strong points: resistance to atmospheric moisture, no rapid decomposition, and manageable safety characteristics—a trio that simplifies its storage and shipment.
End users often highlight the product’s smooth integration into coupling and substitution steps. Some labs tell us about failed reactions with other suppliers’ materials, usually because a few extra tenths of a percent in impurities derailed their synthesis. Our batch records consistently show a low impurity profile. This lowers troubleshooting on the user’s end and ultimately saves time—an asset that shows its value only after a few production cycles.
We have worked with a wide range of amine hydrochloride salts over the years, observing how slight differences in structure create outsized changes in chemical behavior. 2,4-Dimethoxybenzylamine Hydrochloride stands out in two primary respects: its aromatic substitution pattern and the stability delivered by its methoxy groups.
Comparing DMBA-HCl with less substituted benzylamine derivatives reveals tangible processing differences. The dual methoxy groups not only direct reactivity in downstream coupling but also shift solubility parameters. Some customers, attempting to substitute DMBA-HCl with lighter or less functionalized benzylamine salts, encounter solubility limits or unwanted side products that simply do not occur with our material. Our hands-on production cycles confirmed these observations—small changes to the substitution pattern introduce new impurities or slow down routine crystallization steps.
Further, unlike some related hydrochloride salts, DMBA-HCl’s solid form resists caking and breakdown under regular warehouse conditions. We learned this after multiple storage stability studies. Manufacturers and researchers often overlook this point until repeated exposure to air or fluctuating humidity leads to product changes. We optimized both primary packaging and warehouse climate control directly in response to these observations. Every detail matters: from shipment shelf life to physical handling, DMBA-HCl simply behaves better during industrial use compared with more hygroscopic, less stable amine salts.
Real value emerges in daily operations. There’s little glamour in maintaining a tight workflow for solvent handling or studying the best neutralization profiles—yet overlooking those steps brings disaster. Early on, our team experienced the frustration that follows a seemingly routine batch that deviates due to trace contaminants. Less rigorous neutralization introduced minor side salts, enough to ruin the appearance and solubility needed by laboratories. Our process now includes extra monitoring for trace contaminants; not because certifications demand it, but because end users encounter problems that can trace their root causes back to source batch characteristics.
Storage presents its own challenges. While DMBA-HCl remains stable, it can absorb moisture if left in open air for too long. We learned that triple-sealed containers in controlled humidity zones work best. Shipping into extreme climates confirmed our approach: containers arriving in hot, damp conditions showed no sign of lumpiness or breakdown. Over time, we learned which packaging suppliers could match our standards and which fell short. Now, every dispatched unit rests inside low-permeability, heat-sealed liners, boxed for resilience.
Most importantly, our continuous production cycles allow us to quickly cycle between orders and promptly refill stock. This offers security for long-running projects. Customers working on clinical trial APIs or advanced chemical building blocks require continuity in both material quality and physical form. With each production run, the feedback loop shortens—customers return not because we promise the lowest price, but because their chemistry performs better with a material whose origin is consistent, whose impurities predictably stay below critical thresholds, and whose physical handling matches their needs batch after batch.
Academic and commercial researchers alike demand more than basic purity. They look for proven handling, detailed traceability, and performance history. Synthesis teams that rely on DMBA-HCl trust our product because our background aligns with the rigors of their own work. In peptide chemistry, the 2,4-dimethoxy protecting group offers clean removals, aiding downstream edits and modifications. In medicinal chemistry, the hydrochloride salt unlocks new pathways with minimal by-products. Crafting these features takes more than adherence to guidelines; it takes a persistent dialogue between production chemists and end users, which shapes our ongoing improvements.
Every quality report we deliver includes tail-end residue analysis and detailed chromatographic records, because once bulk supply makes its way into sensitive synthesis, the margin for unexpected reactivity vanishes. From scale-up project managers to bench chemists fine-tuning new routes, there’s a growing demand for both transparency and technical support from their suppliers. Our customers often approach us for additional analytical data, custom particle sizes, or consultation on storage and reactivity. Having real-time feedback from our own lab chemists—who use the same product for internal projects—lets us preempt common challenges and recommend best storage, dissolution, or transfer protocols.
Long before we reach the point of shipping, most issues surface in the upstream process. Variations in raw materials—especially the benzylating agents or methoxylated intermediates—affect yield, reactivity, and purity profile. We select only verified suppliers for these components, and each lot comes with a chain of traceability dating back years. Fluctuations in feedstocks sometimes drive up costs, but skipping this process would cost more in lost time and customer trust. We have sometimes faced batch failures due to upstream quality—there’s no shortcut. Investing in upstream control always repays itself by minimizing headaches further along the path.
We also see recurring questions about safe handling. Though DMBA-HCl presents few acute hazards, we work daily with our operators to maintain clean work environments, effective ventilation, and proper training. Routine exposure reviews, coupled with regular updates to safety procedures, keep our teams alert to best practices. This attention translates into a track record free of spills or loss-of-control incidents—and a solid record for safe deliveries worldwide.
Global research and manufacturing trends don’t sit still. We’ve seen new inquiries come from unexpected industries—materials science, digital electronics, and even pigment technology. Our ability to maintain consistent output in the face of fluctuating demand depends entirely on scalable reactors and flexible logistics—all shaped by years spent building onsite infrastructure. Where some producers suffer from procurement gaps or shipping delays, our vertically integrated workflow allows us to shift between production priorities without long lead times.
Emerging sustainability expectations also impact our operations. We continuously review solvent choices and waste control strategies. Our chemists optimized reaction sequences to reduce solvent use and recycle by-products. Regulatory requirements now push for lower emissions and stronger monitoring, but these remain easier to meet by investing early in better environmental controls. Our choice to operate with real-time emission trackers, closed-loop solvent systems, and regular external audits paid off not just in compliance, but in smoother operation and higher staff confidence.
As manufacturers, our relationships with users of DMBA-HCl develop over repeated, reliable performance—not promotional campaigns or one-off special deals. We speak directly with purchasing managers, medicinal chemists, and scale-up team leads about real needs. We keep extensive records on each batch, so a researcher receiving an order next year can request complete trace information back to the day of synthesis.
Trust builds through the hard, unglamorous work—retesting retained samples from older batches, analyzing trends in impurity profiles, adjusting process controls when customer feedback identifies new requirements. Several of our long-term customers started with small test orders, then gradually shifted more of their requirement to our production as we demonstrated consistency. The biggest motivator remains performance in the field: if DMBA-HCl works as expected batch after batch, more users ask for the same source.
Development never truly ends. We consistently field requests for different salt forms, customized particle sizes, and higher-purity options for regulated industries. Rolling out improvements takes partnership—dialogue with R&D teams, willingness to share analytical insights, and readiness to tweak production in response to fresh scientific findings. Our aim isn’t just more volume but deeper technical integration with customers’ efforts. The same care that built today’s DMBA-HCl production now drives our pursuit of new grades, better packaging, and closer technical support channels.
DMBA-HCl’s chemical identity hasn’t changed in decades, but the conditions under which it meets next-generation research and industry keep evolving. Each batch draws on direct learning—continuous technical checks, live feedback from users, investment in better equipment, and an openness to adapt. New entrants into the market sometimes treat DMBA-HCl as a commodity, but there are no shortcuts to making a product that truly earns the confidence of chemists at the bench or in the plant. We bring experience not as a slogan but as a living process, revisited, refined, and shared with those building the chemistry of tomorrow.